Results 111 to 120 of about 929 (148)
Some of the next articles are maybe not open access.
California medicine, 1971
Sphingolipidoses are an heterogeneous group of inherited disorders of lipid metabolism affecting primarily the central nervous system. These disorders occur chiefly in the pediatric population, and the degenerative nature of the disease processes is generally characterized by diffuse and progressive involvement of neurones (gray matter) with ...
openaire +1 more source
Sphingolipidoses are an heterogeneous group of inherited disorders of lipid metabolism affecting primarily the central nervous system. These disorders occur chiefly in the pediatric population, and the degenerative nature of the disease processes is generally characterized by diffuse and progressive involvement of neurones (gray matter) with ...
openaire +1 more source
Postgraduate Medicine, 1977
An outline of the pathways of catabolism of four sphingolipids to ceramide, along with structural details of a few constituents, serves as a framework for better understanding of the sphingolipidoses. The four sphingolipids are sulfatide, sphingomyelin, globoside, and ganglioside GM1.
openaire +2 more sources
An outline of the pathways of catabolism of four sphingolipids to ceramide, along with structural details of a few constituents, serves as a framework for better understanding of the sphingolipidoses. The four sphingolipids are sulfatide, sphingomyelin, globoside, and ganglioside GM1.
openaire +2 more sources
Biochemical Relationships in the Neuronal Sphingolipidoses
Developmental Medicine & Child Neurology, 1970SUMMARYOut of a complex and difficult classification of a group of neurodegenerative disorders there is emerging what appears at first sight to be an equally difficult and complex chemical classification. This, in contrast to the former, can be supported by precise chemical and, in several instances, enzymic analysis and the diagnosis in these cases is
openaire +2 more sources
Chemical Models and Chemotherapy in the Sphingolipidoses
1976As I left the previous Sphingolipid Symposium that was held here in 1971, I decided to attempt intervening in glucocerebroside metabolism by synthesizing suitable enzyme inhibitors. It seemed possible to help the victims of Gaucher’s disease, and possibly other sphingolipidoses, by slowing down the synthesis of the sphingolipid that accumulates.
openaire +2 more sources
Progress in investigations of sphingolipidoses
Acta Neuropathologica, 1978M, Adachi, L, Schneck, B W, Volk
openaire +2 more sources
Transactions of the American Neurological Association, 1998
L, WIENER, R G, BERRY
openaire +3 more sources
L, WIENER, R G, BERRY
openaire +3 more sources
Recent advances in the biochemistry and genetics of sphingolipidoses
Brain and Development, 2004Hatice Asuman Ozkara
exaly